Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

Heterogeneous Catalysis

Heterogeneous Catalysis

Heterogeneous catalysis involves a catalyst in a different phase from the reactants. It is a process where the catalyst and the reactants are in distinct phases, typically solid and gas or liquid.Most heterogeneous catalysts are metals, metal oxides, or acids. The list includes transition metals like iron (Fe), cobalt (Co), nickel (Ni), palladium (Pd), platinum (Pt), chromium (Cr), manganese (Mn), tungsten (W), silver (Ag), and copper (Cu). These metals possess partially vacant d orbitals that...

Catalysis

Catalysis

The presence of a catalyst affects the rate of a chemical reaction. A catalyst is a substance that can increase the reaction rate without being consumed during the process. A basic comprehension of a catalysts’ role during chemical reactions can be understood from the concept of reaction mechanisms and energy diagrams.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Metabolic pathways and cell death modalities in diabetic complications: unraveling pyroptosis, ferroptosis, cuproptosis, and disulfidptosis.

Cell death discovery·2026

Same author

Efficacy of SGLT2i and GLP-1RA in Acute Myocardial Infarction: A Meta-Analysis of Randomized Controlled Trials.

Current medicinal chemistry·2026

Same author

Metformin Inhibits Inflammation by Targeting the NLRP3 Inflammasome: Linking NF-κB/NEK7/AMPK Signaling to Mitochondrial Function.

Journal of inflammation research·2026

Same author

Current progress in production and identification of umami peptides from soybeans and soybean products: A review.

Food chemistry·2026

Same author

Causal association between glucagon-like peptide-1 receptor agonists and mental disorders: insight from genetic and real-world evidence.

Journal of affective disorders·2026

Same author

Dapagliflozin ameliorates myocardial ischemia/reperfusion injury by modulating EGFR signaling and targeting NCOA4-mediated ferritinophagy.

Life sciences·2026

Search research articles

Related Experiment Video

Updated: Apr 21, 2026

Anionic Polymerization of an Amphiphilic Copolymer for Preparation of Block Copolymer Micelles Stabilized by π-π Stacking Interactions

Anionic Polymerization of an Amphiphilic Copolymer for Preparation of Block Copolymer Micelles Stabilized by π-π Stacking Interactions

Published on: October 10, 2016

Programming the beating heart with polymer catalysis: a therapeutic microenvironment revolution.

Yanqi Wang¹, Jun Fu¹, Miao Zou¹

¹Department of Metabolism and Endocrinology, the Second Affiliated Hospital of Nanchang University, Nanchang, China.

Journal of Nanobiotechnology

|April 19, 2026

Summary

Intelligent polymer nanocatalysts actively remodel cardiovascular disease microenvironments. These advanced materials offer superior biosafety and therapeutic performance for conditions like heart attack and atherosclerosis.

Keywords:

Cardiovascular diseases Intelligent nanoparticle Nanocatalytic therapeutics Pathophysiological targets Reactive oxygen species

More Related Videos

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

Related Experiment Videos

Last Updated: Apr 21, 2026

Anionic Polymerization of an Amphiphilic Copolymer for Preparation of Block Copolymer Micelles Stabilized by π-π Stacking Interactions

Anionic Polymerization of an Amphiphilic Copolymer for Preparation of Block Copolymer Micelles Stabilized by π-π Stacking Interactions

Published on: October 10, 2016

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

Area of Science:

Biomaterials Science
Nanotechnology
Cardiovascular Medicine

Background:

Cardiovascular diseases (CVDs) stem from a dysregulated microenvironment with oxidative stress, low nitric oxide, and clotting issues.
Conventional treatments often view polymers solely as drug carriers, not active therapeutic agents.

Purpose of the Study:

To present polymers as intelligent, stimuli-responsive catalytic platforms for cardiovascular disease treatment.
To detail the design principles and therapeutic applications of polymer nanocatalysts in CVDs.

Main Methods:

Reviewing enzyme-mimetic copolymer networks, gas therapy nanoparticles, intelligent hydrogels, and surface-functionalized vectors.
Evaluating polymeric architectures leveraging dynamic covalent bonding and biocompatible backbones.
Assessing therapeutic performance in acute myocardial infarction, atherosclerosis, and ischemia-reperfusion injury.

Main Results:

Polymer nanocatalysts demonstrate superior biosafety and biological integration compared to metal catalysts.
These systems actively remodel pathological microenvironments by sensing and responding to stimuli.
Significant therapeutic efficacy was observed across various CVD models.

Conclusions:

Polymer nanocatalysis offers a transformative design philosophy for cardiovascular medicine.
Challenges include long-term biosafety and scalable manufacturing.
Polymer nanocatalysis is positioned for future personalized theranostic strategies in CVDs.